Hematology/Oncology Specialty Account Rep

Pharmacosmos Therapeutics Inc.; Chicago (IL); On-site; USD 150,000 - 164,000; Full time

Job summary

Pharmacosmos Therapeutics Inc. is seeking a Specialty Account Representative for the Chicago North region. The role focuses on hematology/oncology markets, managing complex accounts, and developing strategic relationships with key thought leaders across community oncology and health systems.

The ideal candidate has 6+ years in pharmaceutical sales, 3+ years in specialty pharma, and buy-and-bill/HEMONC experience. Travel up to 25–30% is required as part of regional coverage.

Qualifications

• Minimum 6 years of current pharmaceutical sales experience.
• Minimum 3 years of specialty pharmaceutical experience.
• Buy-and-bill AND HEM/ONC experience preferred.
• Demonstrated knowledge of account-based selling and reimbursement considerations.
• Proven sales success in Hematology/Oncology and hospital accounts or various sites of care.

Responsibilities

• Meet or exceed all territory sales objectives.
• Achieve territory objectives through planning, marketing strategies and stakeholder engagement.
• Maintain and expand customer base by building rapport with key customers and identifying opportunities.
• Implement national and regional initiatives and align with corporate strategy.
• Apply selling processes tailored to meet customer needs and product portfolios.
• Collaborate with cross-functional teams including Marketing, Training, Strategy and Medical Affairs.

Skills

Pharmaceutical sales

Specialty pharma

Buy-and-bill

Hematology/Oncology

Account management

Travel readiness

Job description

Pharmacosmos Therapeutics Inc. is seeking a Specialty Account Representative for the Chicago North region. The role focuses on hematology/oncology markets, managing complex accounts, and developing strategic relationships with key thought leaders across community oncology and health systems.

The ideal candidate has 6+ years in pharmaceutical sales, 3+ years in specialty pharma, and buy-and-bill/HEMONC experience. Travel up to 25–30% is required as part of regional coverage.